FolioLanternBeta
KLRAKailera Therapeutics, Inc.

Ronald Renaud Jr.

CEO & President, Director at Kailera Therapeutics, Inc., as of Jun 11, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
38K
shares held after the latest filing, Kailera Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2
companies filed for

Last filing: Jun 11, 2026.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Kailera Therapeutics, Inc. (KLRA)CEO & President, DirectorApr 16, 2026Jun 11, 2026
Ptc Therapeutics, Inc. (PTCT)Former DirectorJun 11, 2014Jan 5, 2017

Also a director at

Ptc Therapeutics, Inc. (PTCT) (no filing in the last 18 months)

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.